SUCCINYLCHOLINE

SUCCINYLCHOLINE was reported 2257 times

SUCCINYLCHOLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSWS SYNDROME 6 0.2609
1 MEMBRANE STABILISING EFFECT 1 0.2000
2 PSEUDOCHOLINESTERASE DEFICIENCY 13 0.2000
3 TRACHEAL DEVIATION 16 0.1818
4 UREAPLASMA TEST POSITIVE 2 0.1538
5 NEGATIVE PRESSURE PULMONARY OEDEMA 14 0.1429
6 HYPERTHERMIA MALIGNANT 192 0.1289
7 DOPAMINE SUPERSENSITIVITY PSYCHOSIS 2 0.1250
8 BLOOD CHOLINESTERASE ABNORMAL 1 0.1000
9 NEUROMUSCULAR BLOCKING THERAPY 3 0.0909
10 PHRENIC NERVE PARALYSIS 16 0.0731
11 ACQUIRED ANTITHROMBIN III DEFICIENCY 1 0.0714
12 END-TIDAL CO2 INCREASED 3 0.0652
13 MYOTONIC DYSTROPHY 5 0.0641
14 ALLERGY TEST NEGATIVE 8 0.0513
15 NEUROMUSCULAR BLOCK PROLONGED 18 0.0488
16 CHEST WALL RIGIDITY 3 0.0469
17 SCHIZENCEPHALY 2 0.0444
18 DIPHTHERIA 2 0.0426
19 PHAEOCHROMOCYTOMA CRISIS 8 0.0377
20 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 2 0.0364
21 ANAL SPHINCTER HYPERTONIA 1 0.0345
22 PIGMENT NEPHROPATHY 3 0.0337
23 CEREBRAL HAEMORRHAGE FOETAL 2 0.0328
24 AGITATION POSTOPERATIVE 2 0.0317
25 AIRWAY PEAK PRESSURE INCREASED 4 0.0263
26 CARDIOPULMONARY BYPASS 1 0.0256
27 DELAYED RECOVERY FROM ANAESTHESIA 24 0.0253
28 UNWANTED AWARENESS DURING ANAESTHESIA 8 0.0244
29 RENAL ISCHAEMIA 13 0.0238
30 NEUROMUSCULAR BLOCKADE 5 0.0223
31 LONG QT SYNDROME CONGENITAL 2 0.0222
32 MATERNAL EXPOSURE DURING DELIVERY 22 0.0222
33 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
34 POSTOPERATIVE DELIRIUM 4 0.0202
35 GENITAL ABSCESS 8 0.0198
36 PCO2 INCREASED 14 0.0197
37 MYOCARDIAL DEPRESSION 5 0.0194
38 FOETAL MOVEMENT DISORDER 1 0.0192
39 RESPIRATORY PARALYSIS 3 0.0187
40 ELECTROCONVULSIVE THERAPY 2 0.0183
41 DRUG-DEVICE INTERACTION 2 0.0180
42 EPIDURAL ANAESTHESIA 1 0.0179
43 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 2 0.0179
44 PO2 INCREASED 9 0.0178
45 PNEUMONITIS ASPIRATION 6 0.0175
46 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 6 0.0172
47 POSTICTAL PARALYSIS 4 0.0165
48 ANAESTHETIC COMPLICATION NEUROLOGICAL 14 0.0155
49 RHYTHM IDIOVENTRICULAR 5 0.0154
50 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 1 0.0154
51 PROCEDURAL HYPOTENSION 13 0.0153
52 AIRWAY COMPLICATION OF ANAESTHESIA 4 0.0152
53 HYPOTENSIVE TRANSFUSION REACTION 1 0.0152
54 NEONATAL RESPIRATORY DEPRESSION 5 0.0151
55 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
56 HEPATIC VEIN DILATATION 1 0.0139
57 HARLEQUIN SYNDROME 1 0.0137
58 TRACHEAL INJURY 2 0.0136
59 DIAPHRAGMATIC INJURY 1 0.0135
60 PERINEAL ABSCESS 6 0.0133
61 CARDIAC CONTRACTILITY DECREASED 1 0.0130
62 NECROTISING SOFT TISSUE INFECTION 3 0.0130
63 BREAST PROSTHESIS REMOVAL 1 0.0123
64 BRADYCARDIA FOETAL 10 0.0120
65 MITOCHONDRIAL DNA MUTATION 1 0.0116
66 UTERINE ATONY 3 0.0115
67 BREATH SOUNDS DECREASED 1 0.0114
68 DUCHENNE MUSCULAR DYSTROPHY 1 0.0108
69 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 1 0.0106
70 SCROTAL ABSCESS 4 0.0106
71 METAPNEUMOVIRUS PNEUMONIA 1 0.0104
72 PSYCHOGENIC SEIZURE 9 0.0096
73 EAR DRYNESS 1 0.0095
74 VENTRICULAR TACHYARRHYTHMIA 3 0.0094
75 FOETAL MALPRESENTATION 1 0.0093
76 INTERSTITIAL LUNG ABNORMALITY 1 0.0088
77 PROPOFOL INFUSION SYNDROME 6 0.0085
78 ENDOTRACHEAL INTUBATION COMPLICATION 5 0.0085
79 MYOGLOBINAEMIA 1 0.0085
80 MYOCLONIC EPILEPSY 12 0.0079
81 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
82 CONFUSION POSTOPERATIVE 1 0.0076
83 BLOOD PH DECREASED 13 0.0076
84 BLOOD GASES ABNORMAL 4 0.0074
85 DRUG EFFECT PROLONGED 4 0.0072
86 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
87 DIABETES INSIPIDUS 17 0.0071
88 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
89 SYMPTOM MASKED 5 0.0069
90 BLOOD BICARBONATE DECREASED 13 0.0069
91 ACCELERATED IDIOVENTRICULAR RHYTHM 1 0.0068
92 GASTRIC HYPOMOTILITY 2 0.0065
93 ASPERGILLUS TEST POSITIVE 2 0.0065
94 INTRA-ABDOMINAL PRESSURE INCREASED 1 0.0064
95 RETROPERITONEAL ABSCESS 2 0.0063
96 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
97 HYPORESPONSIVE TO STIMULI 7 0.0060
98 LARYNGOSPASM 16 0.0059
99 FOETAL EXPOSURE DURING DELIVERY 4 0.0059
100 FOETAL HEART RATE DECELERATION ABNORMALITY 4 0.0057
101 TRYPTASE INCREASED 4 0.0056
102 CLONUS 15 0.0055
103 ADMINISTRATION SITE REACTION 2 0.0052
104 FRACTURE MALUNION 1 0.0052
105 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
106 DEAFNESS PERMANENT 1 0.0051
107 RESPIRATORY ACIDOSIS 20 0.0051
108 CELLULITIS GANGRENOUS 1 0.0051
109 ELECTROENCEPHALOGRAM ABNORMAL 16 0.0051
110 TRANSIENT TACHYPNOEA OF THE NEWBORN 2 0.0051
111 OPISTHOTONUS 4 0.0050
112 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
113 VULVAL ABSCESS 2 0.0049
114 METHAEMOGLOBINAEMIA 11 0.0047
115 INFERIOR VENA CAVA DILATATION 1 0.0047
116 OXYGEN SATURATION ABNORMAL 13 0.0046
117 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
118 MATERNAL CONDITION AFFECTING FOETUS 1 0.0045
119 COLORECTAL ADENOCARCINOMA 1 0.0045
120 ALLERGY TEST POSITIVE 2 0.0044
121 KOUNIS SYNDROME 10 0.0044
122 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
123 VASOPLEGIA SYNDROME 7 0.0043
124 COLD TYPE HAEMOLYTIC ANAEMIA 1 0.0043
125 STATUS ASTHMATICUS 2 0.0042
126 ARRESTED LABOUR 1 0.0042
127 HYPERCAPNIA 12 0.0040
128 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 13 0.0039
129 APNOEA 30 0.0038
130 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 2 0.0038
131 MYOGLOBINURIA 2 0.0038
132 BLOOD CHOLINESTERASE DECREASED 1 0.0036
133 DYSCHROMATOPSIA 3 0.0036
134 BACTERIURIA 2 0.0035
135 SEROTONIN SYNDROME 68 0.0035
136 CARBUNCLE 1 0.0035
137 COLON DYSPLASIA 1 0.0035
138 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
139 HAEMATOMA INFECTION 2 0.0035
140 PSEUDOMONAL SEPSIS 6 0.0034
141 GROIN ABSCESS 4 0.0034
142 ANTEROGRADE AMNESIA 2 0.0033
143 LUNG INJURY 1 0.0033
144 MYXOEDEMA COMA 1 0.0033
145 NEURODEGENERATIVE DISORDER 2 0.0032
146 FOETAL HEART RATE DECREASED 2 0.0032
147 MUSCLE TONE DISORDER 1 0.0032
148 ANAPHYLACTIC SHOCK 81 0.0031
149 CYANOSIS NEONATAL 2 0.0031
150 MITRAL VALVE REPAIR 1 0.0031
151 ADMINISTRATION SITE SWELLING 1 0.0031
152 DRUG CLEARANCE DECREASED 4 0.0031
153 DELIVERY 2 0.0030
154 GENITAL INFECTION 1 0.0030
155 HAEMODYNAMIC INSTABILITY 23 0.0030
156 LYMPHOCELE 2 0.0030
157 ANAESTHETIC COMPLICATION 8 0.0030
158 BENIGN NEOPLASM OF SKIN 1 0.0030
159 GAZE PALSY 5 0.0029
160 POSTICTAL STATE 3 0.0029
161 TONGUE PARALYSIS 2 0.0028
162 DRUG-GENETIC INTERACTION 1 0.0028
163 HEART VALVE STENOSIS 1 0.0028
164 BACTERIAL DISEASE CARRIER 2 0.0027
165 CLONIC CONVULSION 2 0.0027
166 ECLAMPSIA 1 0.0027
167 PERIRECTAL ABSCESS 3 0.0027
168 RESPIRATORY TRACT OEDEMA 2 0.0027
169 MEDIASTINAL DISORDER 1 0.0027
170 BREAST RECONSTRUCTION 1 0.0027
171 STATUS EPILEPTICUS 30 0.0027
172 ANISOCORIA 1 0.0026
173 ELECTROCARDIOGRAM PR PROLONGATION 2 0.0026
174 ADENOIDECTOMY 1 0.0026
175 CARDIOVASCULAR SYMPTOM 1 0.0026
176 NORMAL NEWBORN 14 0.0026
177 GRIMACING 2 0.0026
178 METAPNEUMOVIRUS INFECTION 2 0.0026
179 MUSCLE DISCOMFORT 2 0.0025
180 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
181 EYELID FUNCTION DISORDER 2 0.0025
182 FOETAL DEATH 13 0.0025
183 ELECTROMECHANICAL DISSOCIATION 2 0.0025
184 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
185 INFANTILE APNOEA 2 0.0025
186 BREAST OPERATION 2 0.0024
187 BRADYARRHYTHMIA 4 0.0024
188 DEVELOPMENTAL HIP DYSPLASIA 2 0.0024
189 TWIN PREGNANCY 2 0.0024
190 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
191 HYPERREFLEXIA 8 0.0023
192 MUSCLE CONTRACTIONS INVOLUNTARY 8 0.0023
193 HYPERLEUKOCYTOSIS 2 0.0023
194 UPPER AIRWAY OBSTRUCTION 2 0.0023
195 DELUSION OF GRANDEUR 1 0.0022
196 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
197 TRISMUS 11 0.0021
198 ANAPHYLACTOID SHOCK 1 0.0021
199 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
200 HELPLESSNESS 1 0.0021
201 NYSTAGMUS 11 0.0021
202 STRESS CARDIOMYOPATHY 12 0.0021
203 PRODUCT PACKAGING CONFUSION 5 0.0021
204 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
205 TYPE I HYPERSENSITIVITY 7 0.0020
206 PRODUCT MEASURED POTENCY ISSUE 2 0.0020
207 NECROTISING FASCIITIS 7 0.0020
208 NEONATAL RESPIRATORY FAILURE 1 0.0020
209 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
210 SYSTOLIC DYSFUNCTION 2 0.0019
211 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
212 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
213 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
214 EPIGLOTTITIS 1 0.0018
215 KIDNEY ENLARGEMENT 2 0.0018
216 CLAUSTROPHOBIA 2 0.0018
217 GROIN INFECTION 1 0.0018
218 BLOOD MAGNESIUM ABNORMAL 1 0.0018
219 RESPIRATORY DEPRESSION 22 0.0018
220 CATHETER RELATED COMPLICATION 2 0.0018
221 APNOEIC ATTACK 1 0.0018
222 SEIZURE LIKE PHENOMENA 3 0.0018
223 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
224 CEREBRAL VENTRICLE DILATATION 2 0.0017
225 IRREGULAR BREATHING 1 0.0017
226 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
227 INCISION SITE PAIN 2 0.0017
228 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
229 MENINGOMYELOCELE 1 0.0017
230 PRETERM PREMATURE RUPTURE OF MEMBRANES 2 0.0017
231 CRANIOCEREBRAL INJURY 5 0.0017
232 CARDIAC PROCEDURE COMPLICATION 1 0.0016
233 HELLP SYNDROME 1 0.0016
234 VENTRICULAR FIBRILLATION 18 0.0016
235 TACHYARRHYTHMIA 4 0.0016
236 DRY GANGRENE 1 0.0016
237 PREMATURE DELIVERY 25 0.0016
238 APGAR SCORE LOW 2 0.0016
239 ASPIRATION 17 0.0016
240 ENTEROCOCCUS TEST POSITIVE 1 0.0015
241 SLOW RESPONSE TO STIMULI 2 0.0015
242 TONIC CLONIC MOVEMENTS 2 0.0015
243 KLEBSIELLA TEST POSITIVE 1 0.0015
244 PARALYSIS 22 0.0015
245 HYPOVENTILATION 5 0.0015
246 HYPERMAGNESAEMIA 1 0.0015
247 PARTIAL SEIZURES 8 0.0015
248 POSTPARTUM HAEMORRHAGE 2 0.0015
249 ANAL ABSCESS 8 0.0015
250 ABSCESS NECK 1 0.0015
251 CYTOKINE STORM 1 0.0015
252 VENTRICULAR TACHYCARDIA 24 0.0015
253 PERITONEAL HAEMORRHAGE 2 0.0014
254 FOETAL HYPOKINESIA 1 0.0014
255 MUSCLE RIGIDITY 17 0.0014
256 NEONATAL ASPHYXIA 1 0.0014
257 BLOOD MAGNESIUM DECREASED 12 0.0014
258 DISSOCIATIVE DISORDER 1 0.0014
259 ESCHAR 1 0.0014
260 NODAL RHYTHM 2 0.0014
261 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
262 BRAIN HERNIATION 4 0.0013
263 ANAPHYLACTIC REACTION 73 0.0013
264 RUBBER SENSITIVITY 2 0.0013
265 HYPOPARATHYROIDISM 1 0.0013
266 PREMATURE SEPARATION OF PLACENTA 2 0.0013
267 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
268 MYASTHENIC SYNDROME 1 0.0013
269 HYPOTONIA NEONATAL 2 0.0013
270 EXTRADURAL ABSCESS 1 0.0013
271 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
272 PHARYNGEAL PARAESTHESIA 2 0.0013
273 CUSHINGOID 4 0.0012
274 ANAPHYLACTOID REACTION 5 0.0012
275 ACIDOSIS 9 0.0012
276 RHABDOMYOLYSIS 49 0.0012
277 PROCEDURAL COMPLICATION 9 0.0012
278 ACUTE CHEST SYNDROME 1 0.0011
279 MITRAL VALVE DISEASE 2 0.0011
280 CARDIAC ARREST 93 0.0011
281 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
282 BRONCHOSPASM 16 0.0011
283 PREMATURE BABY 33 0.0011
284 CERUMEN IMPACTION 1 0.0011
285 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
286 ABULIA 1 0.0011
287 FOETAL HEART RATE ABNORMAL 1 0.0011
288 ADENOCARCINOMA GASTRIC 1 0.0011
289 BLADDER SPASM 2 0.0011
290 PSYCHOMOTOR RETARDATION 3 0.0011
291 BLOOD CALCIUM DECREASED 12 0.0011
292 NEONATAL RESPIRATORY DISTRESS 1 0.0011
293 PREMATURE LABOUR 6 0.0011
294 NEUTROPHILIA 6 0.0011
295 MECHANICAL VENTILATION 2 0.0011
296 HYPOCOAGULABLE STATE 1 0.0010
297 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
298 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
299 IDIOSYNCRATIC DRUG REACTION 1 0.0010
300 HAEMOPHILUS INFECTION 1 0.0010
301 BRADYCARDIA 54 0.0010
302 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
303 DEVICE RELATED THROMBOSIS 1 0.0010
304 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
305 DILATED CARDIOMYOPATHY 1 0.0010
306 AUTONOMIC NEUROPATHY 1 0.0010
307 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
308 SINUS TACHYCARDIA 14 0.0010
309 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
310 PSYCHOTIC SYMPTOM 2 0.0010
311 BRUGADA SYNDROME 1 0.0010
312 BONE MARROW OEDEMA 1 0.0010
313 HYPOXIA 34 0.0010
314 AXILLARY MASS 1 0.0010
315 MICROCYTIC ANAEMIA 2 0.0010
316 RESPIRATORY RATE DECREASED 3 0.0010
317 IMPAIRED GASTRIC EMPTYING 13 0.0010
318 HYPERKALAEMIA 33 0.0009
319 ABSCESS LIMB 4 0.0009
320 VENTRICULAR HYPOKINESIA 3 0.0009
321 HYPERPHOSPHATAEMIA 2 0.0009
322 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
323 LARYNGEAL CANCER 1 0.0009
324 PARESIS 2 0.0009
325 TORSADE DE POINTES 7 0.0009
326 ACUTE PULMONARY OEDEMA 5 0.0009
327 EYELID DISORDER 2 0.0009
328 NEPHROGENIC ANAEMIA 4 0.0009
329 MACROCYTOSIS 1 0.0009
330 HYPERTENSIVE EMERGENCY 1 0.0008
331 FOETAL EXPOSURE DURING PREGNANCY 69 0.0008
332 METABOLIC ACIDOSIS 27 0.0008
333 PULSE ABSENT 4 0.0008
334 LIVE BIRTH 7 0.0008
335 ESCHERICHIA TEST POSITIVE 1 0.0008
336 RADIUS FRACTURE 2 0.0008
337 CLOSTRIDIUM COLITIS 1 0.0008
338 MAJOR DEPRESSION 6 0.0008
339 EXPOSURE DURING PREGNANCY 51 0.0008
340 PERSECUTORY DELUSION 2 0.0008
341 HYPERPARATHYROIDISM SECONDARY 2 0.0008
342 BRADYCARDIA NEONATAL 1 0.0008
343 PLATELET DISORDER 2 0.0008
344 APPENDICITIS PERFORATED 2 0.0008
345 INCREASED BRONCHIAL SECRETION 2 0.0008
346 HEPATOSPLENOMEGALY 2 0.0008
347 ADENOCARCINOMA PANCREAS 1 0.0008
348 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
349 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
350 BILIARY OBSTRUCTION 1 0.0008
351 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
352 CIRCULATORY COLLAPSE 13 0.0008
353 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
354 CATATONIA 4 0.0008
355 ENCEPHALITIS AUTOIMMUNE 1 0.0008
356 FEELING GUILTY 1 0.0008
357 PNEUMOTHORAX 12 0.0008
358 LOW BIRTH WEIGHT BABY 6 0.0008
359 AREFLEXIA 2 0.0007
360 ANION GAP INCREASED 1 0.0007
361 WRONG PRODUCT ADMINISTERED 5 0.0007
362 ENCEPHALOPATHY 18 0.0007
363 BEZOAR 1 0.0007
364 SINUS BRADYCARDIA 7 0.0007
365 LUNG CONSOLIDATION 2 0.0007
366 ENDOTRACHEAL INTUBATION 2 0.0007
367 CULTURE URINE POSITIVE 1 0.0007
368 RENAL TUBULAR DISORDER 2 0.0007
369 HYPERPYREXIA 3 0.0007
370 AUDITORY DISORDER 1 0.0007
371 HYPOTONIA 7 0.0007
372 JUDGEMENT IMPAIRED 1 0.0007
373 HYPOTENSION 138 0.0007
374 PHYSICAL DISABILITY 3 0.0007
375 MYASTHENIA GRAVIS CRISIS 1 0.0007
376 ANGIOPLASTY 1 0.0007
377 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
378 TACHYCARDIA 59 0.0007
379 DRUG INTERACTION 105 0.0007
380 HYPERTHERMIA 5 0.0007
381 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
382 BLOOD PRESSURE IMMEASURABLE 1 0.0007
383 LARYNGEAL OEDEMA 4 0.0006
384 LOCALISED OEDEMA 3 0.0006
385 BRAIN DEATH 2 0.0006
386 COAGULATION TIME PROLONGED 1 0.0006
387 DRUG EFFECT INCREASED 2 0.0006
388 INHIBITORY DRUG INTERACTION 1 0.0006
389 CARDIAC TAMPONADE 3 0.0006
390 ANTICHOLINERGIC SYNDROME 1 0.0006
391 SUBCUTANEOUS ABSCESS 3 0.0006
392 INTRA-UTERINE DEATH 1 0.0006
393 HYPOGLYCAEMIA NEONATAL 1 0.0006
394 LIVER ABSCESS 2 0.0006
395 BREATH SOUNDS ABNORMAL 3 0.0006
396 DEAFNESS NEUROSENSORY 2 0.0006
397 NEAR DEATH EXPERIENCE 2 0.0006
398 CARDIAC FAILURE ACUTE 4 0.0006
399 HYPOTHERMIA 6 0.0006
400 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
401 ECCHYMOSIS 4 0.0006
402 CEREBRAL ISCHAEMIA 3 0.0006
403 UNRESPONSIVE TO STIMULI 15 0.0006
404 CARDIO-RESPIRATORY ARREST 24 0.0006
405 EXTREMITY NECROSIS 1 0.0006
406 POST PROCEDURAL COMPLICATION 11 0.0006
407 BLOOD LACTIC ACID INCREASED 3 0.0006
408 JUGULAR VEIN THROMBOSIS 1 0.0006
409 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
410 MONOPARESIS 1 0.0006
411 HYPERSEXUALITY 1 0.0005
412 CONTRAST MEDIA ALLERGY 1 0.0005
413 AURA 1 0.0005
414 HEPATIC NECROSIS 2 0.0005
415 INTERVERTEBRAL DISCITIS 1 0.0005
416 HYPERTONIA 3 0.0005
417 INTENTIONAL MISUSE 1 0.0005
418 HYPOREFLEXIA 1 0.0005
419 ATRIOVENTRICULAR BLOCK 4 0.0005
420 SENSATION OF HEAVINESS 2 0.0005
421 CAESAREAN SECTION 6 0.0005
422 TACHYPNOEA 7 0.0005
423 EARLY SATIETY 1 0.0005
424 SPINAL CORD COMPRESSION 2 0.0005
425 ABDOMINAL WALL HAEMATOMA 1 0.0005
426 NASAL SEPTUM DEVIATION 1 0.0005
427 PNEUMONIA FUNGAL 2 0.0005
428 GENE MUTATION 1 0.0005
429 MYOCLONUS 6 0.0005
430 EXPOSURE VIA BREAST MILK 2 0.0005
431 CEREBRAL ATROPHY 2 0.0005
432 MIOSIS 4 0.0005
433 TOXIC SKIN ERUPTION 5 0.0005
434 CORONARY ARTERY THROMBOSIS 1 0.0005
435 RASH MACULO-PAPULAR 11 0.0005
436 SCHIZOPHRENIA 6 0.0005
437 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
438 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
439 DILATATION VENTRICULAR 1 0.0005
440 HEPATIC CYTOLYSIS 6 0.0005
441 ANAEMIA MACROCYTIC 1 0.0005
442 DIABETIC NEPHROPATHY 1 0.0005
443 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
444 POST-TRAUMATIC STRESS DISORDER 3 0.0004
445 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
446 HEPATOCELLULAR DAMAGE 1 0.0004
447 DISTRIBUTIVE SHOCK 1 0.0004
448 RESPIRATORY FAILURE 32 0.0004
449 DISEASE COMPLICATION 2 0.0004
450 RESPIRATION ABNORMAL 3 0.0004
451 SHOCK 10 0.0004
452 BILIRUBIN CONJUGATED INCREASED 1 0.0004
453 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
454 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
455 LONG QT SYNDROME 1 0.0004
456 KIDNEY TRANSPLANT REJECTION 2 0.0004
457 ACUTE RESPIRATORY FAILURE 8 0.0004
458 NO THERAPEUTIC RESPONSE 5 0.0004
459 ACUTE PSYCHOSIS 1 0.0004
460 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
461 INFREQUENT BOWEL MOVEMENTS 1 0.0004
462 LACTIC ACIDOSIS 13 0.0004
463 HYPERNATRAEMIA 2 0.0004
464 BRAIN OEDEMA 5 0.0004
465 DRUG TOLERANCE 2 0.0004
466 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
467 TOXIC ENCEPHALOPATHY 2 0.0004
468 TROPONIN INCREASED 3 0.0004
469 MEAN CELL VOLUME INCREASED 1 0.0004
470 COMPARTMENT SYNDROME 1 0.0004
471 SEDATION 10 0.0004
472 LUNG OPACITY 1 0.0004
473 ABSCESS 6 0.0004
474 BLOOD POTASSIUM ABNORMAL 1 0.0004
475 SENSORY LOSS 3 0.0004
476 BRADYPNOEA 1 0.0004
477 SUBSTANCE ABUSE 3 0.0004
478 CHOLECYSTITIS INFECTIVE 1 0.0004
479 COAGULOPATHY 6 0.0004
480 MENTAL STATUS CHANGES 10 0.0004
481 HAEMODIALYSIS 3 0.0004
482 THERAPY NON-RESPONDER 16 0.0004
483 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
484 DRUG RESISTANCE 9 0.0004
485 CARDIOGENIC SHOCK 5 0.0003
486 ESCHERICHIA SEPSIS 1 0.0003
487 RALES 2 0.0003
488 URINE OUTPUT DECREASED 3 0.0003
489 EOSINOPHILIA 6 0.0003
490 AGITATION 25 0.0003
491 COMA 16 0.0003
492 ANAL INCONTINENCE 3 0.0003
493 METABOLIC ENCEPHALOPATHY 1 0.0003
494 GANGRENE 2 0.0003
495 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
496 RESPIRATORY DISTRESS 9 0.0003
497 DIASTOLIC DYSFUNCTION 1 0.0003
498 ILEUS 4 0.0003
499 OXYGEN SATURATION DECREASED 18 0.0003
500 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
501 DELIRIUM 11 0.0003
502 ABDOMINAL ADHESIONS 1 0.0003
503 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
504 ATELECTASIS 3 0.0003
505 DYSTONIA 6 0.0003
506 BACTERIAL SEPSIS 1 0.0003
507 WALKING AID USER 2 0.0003
508 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
509 COLITIS ISCHAEMIC 2 0.0003
510 TOOTH ABSCESS 3 0.0003
511 MOTOR DYSFUNCTION 3 0.0003
512 BODY TEMPERATURE INCREASED 6 0.0003
513 ACUTE HEPATIC FAILURE 4 0.0003
514 EYE MOVEMENT DISORDER 2 0.0003
515 LEFT VENTRICULAR FAILURE 1 0.0003
516 VENTRICULAR EXTRASYSTOLES 3 0.0003
517 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
518 EXTRASYSTOLES 2 0.0003
519 CAROTID ARTERY STENOSIS 1 0.0003
520 FIBRIN D DIMER INCREASED 1 0.0003
521 HYPERSOMNIA 8 0.0003
522 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
523 SEIZURE 32 0.0003
524 CAROTID ARTERY OCCLUSION 1 0.0003
525 RESTLESSNESS 10 0.0003
526 ALCOHOL USE 1 0.0003
527 AMYLASE INCREASED 1 0.0003
528 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
529 HYPERTENSIVE CRISIS 3 0.0003
530 MALNUTRITION 3 0.0003
531 CHROMATURIA 6 0.0003
532 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
533 ELECTROLYTE IMBALANCE 3 0.0003
534 DELUSION 4 0.0003
535 HYPOALBUMINAEMIA 2 0.0003
536 CARDIOPULMONARY FAILURE 1 0.0003
537 SPLENOMEGALY 3 0.0003
538 PULMONARY HAEMORRHAGE 2 0.0003
539 AFFECTIVE DISORDER 2 0.0003
540 RESPIRATORY ARREST 7 0.0003
541 BACTERAEMIA 3 0.0003
542 SEPSIS 28 0.0003
543 MYASTHENIA GRAVIS 2 0.0002
544 MUSCLE TIGHTNESS 4 0.0002
545 BLOOD POTASSIUM INCREASED 4 0.0002
546 SHOCK HAEMORRHAGIC 2 0.0002
547 AGGRESSION 12 0.0002
548 HYPOKALAEMIA 11 0.0002
549 AORTIC VALVE INCOMPETENCE 1 0.0002
550 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
551 FACIAL PARALYSIS 2 0.0002
552 MYDRIASIS 3 0.0002
553 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
554 SKIN HYPERPIGMENTATION 2 0.0002
555 MULTI-ORGAN FAILURE 4 0.0002
556 CARDIAC MURMUR 2 0.0002
557 PYELONEPHRITIS 2 0.0002
558 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
559 SEPTIC SHOCK 10 0.0002
560 IMMOBILE 1 0.0002
561 INCORRECT PRODUCT STORAGE 3 0.0002
562 TUMOUR LYSIS SYNDROME 2 0.0002
563 LUNG INFILTRATION 2 0.0002
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
565 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
566 CATHETERISATION CARDIAC 1 0.0002
567 CARDIOTOXICITY 2 0.0002
568 PULMONARY OEDEMA 10 0.0002
569 JAUNDICE 6 0.0002
570 DYSKINESIA 9 0.0002
571 AKATHISIA 3 0.0002
572 END STAGE RENAL DISEASE 4 0.0002
573 IMMUNE THROMBOCYTOPENIA 1 0.0002
574 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
575 HYPERTENSION 46 0.0002
576 MUSCLE TWITCHING 5 0.0002
577 GRAND MAL CONVULSION 2 0.0002
578 HYPOMAGNESAEMIA 3 0.0002
579 HEPATIC ENCEPHALOPATHY 2 0.0002
580 ABORTION INDUCED 2 0.0002
581 BLOOD PROLACTIN INCREASED 1 0.0002
582 HYPOCALCAEMIA 4 0.0002
583 ARRHYTHMIA 10 0.0002
584 ENTEROCOCCAL INFECTION 1 0.0002
585 THROMBOTIC MICROANGIOPATHY 2 0.0002
586 HAEMATURIA 7 0.0002
587 RENAL TUBULAR NECROSIS 2 0.0002
588 ACUTE MYOCARDIAL INFARCTION 6 0.0002
589 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
590 EXTRAPYRAMIDAL DISORDER 5 0.0002
591 PNEUMONIA ASPIRATION 5 0.0002
592 ECONOMIC PROBLEM 3 0.0002
593 KLEBSIELLA INFECTION 1 0.0002
594 EYELID PTOSIS 2 0.0002
595 SUBARACHNOID HAEMORRHAGE 2 0.0002
596 LOSS OF CONSCIOUSNESS 25 0.0002
597 FEMORAL NECK FRACTURE 1 0.0002
598 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
599 EJECTION FRACTION DECREASED 3 0.0002
600 TENDERNESS 2 0.0002
601 CYANOSIS 3 0.0002
602 HALLUCINATION, AUDITORY 3 0.0002
603 RENAL PAIN 2 0.0002
604 OBESITY 3 0.0002
605 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
606 BRUXISM 1 0.0002
607 DECREASED ACTIVITY 2 0.0002
608 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
609 NECROSIS 1 0.0002
610 RENAL IMPAIRMENT 15 0.0002
611 CANDIDA INFECTION 3 0.0002
612 REBOUND EFFECT 2 0.0002
613 MITRAL VALVE INCOMPETENCE 2 0.0002
614 CHOLECYSTITIS ACUTE 1 0.0002
615 GENERALISED ERYTHEMA 1 0.0002
616 ENTEROCOLITIS 1 0.0002
617 METABOLIC DISORDER 1 0.0002
618 BLOOD CREATININE INCREASED 11 0.0002
619 ISCHAEMIC STROKE 3 0.0002
620 CHOLECYSTITIS 2 0.0002
621 HYPERLIPIDAEMIA 2 0.0002
622 IRRITABILITY 10 0.0002
623 COMPLICATION OF DEVICE REMOVAL 3 0.0002
624 FOETAL GROWTH RESTRICTION 1 0.0002
625 CEREBRAL INFARCTION 4 0.0002
626 ACUTE KIDNEY INJURY 25 0.0002
627 MUSCLE SPASTICITY 2 0.0002
628 CARDIOMEGALY 2 0.0002
629 CHOLANGITIS 1 0.0002
630 BACTERIAL INFECTION 3 0.0002
631 BLEPHAROSPASM 1 0.0002
632 ANGIOEDEMA 7 0.0002
633 PRESCRIBED OVERDOSE 3 0.0002
634 TOXICITY TO VARIOUS AGENTS 26 0.0002
635 ATRIAL FIBRILLATION 15 0.0002
636 HEPATITIS ACUTE 1 0.0002
637 PLATELET COUNT INCREASED 2 0.0002
638 MENINGITIS 1 0.0001
639 QUALITY OF LIFE DECREASED 2 0.0001
640 INTENTIONAL SELF-INJURY 3 0.0001
641 DRUG EFFECT DECREASED 8 0.0001
642 BLOOD BILIRUBIN INCREASED 4 0.0001
643 PLEURAL EFFUSION 9 0.0001
644 INFARCTION 1 0.0001
645 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
646 CHRONIC KIDNEY DISEASE 11 0.0001
647 DROOLING 1 0.0001
648 LARGE INTESTINE PERFORATION 1 0.0001
649 HYPERTRANSAMINASAEMIA 1 0.0001
650 OVERDOSE 31 0.0001
651 TARDIVE DYSKINESIA 4 0.0001
652 HEPATOCELLULAR INJURY 2 0.0001
653 INTENTIONAL OVERDOSE 9 0.0001
654 CONVULSION 8 0.0001
655 HYPERGLYCAEMIA 5 0.0001
656 GASTROENTERITIS 2 0.0001
657 ACCIDENTAL OVERDOSE 5 0.0001
658 MOUTH HAEMORRHAGE 1 0.0001
659 BLINDNESS TRANSIENT 1 0.0001
660 HYPOPHOSPHATAEMIA 1 0.0001
661 CEREBRAL DISORDER 1 0.0001
662 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
663 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
664 HEPATOTOXICITY 3 0.0001
665 DUODENAL ULCER PERFORATION 1 0.0001
666 HYDRONEPHROSIS 1 0.0001
667 TREATMENT FAILURE 11 0.0001
668 AORTIC ANEURYSM 1 0.0001
669 HEART RATE INCREASED 13 0.0001
670 LIPASE INCREASED 1 0.0001
671 RENAL FAILURE 17 0.0001
672 DRUG SCREEN POSITIVE 1 0.0001
673 BLOOD ALBUMIN DECREASED 1 0.0001
674 ULCER 2 0.0001
675 SENSORY DISTURBANCE 2 0.0001
676 FRUSTRATION TOLERANCE DECREASED 1 0.0001
677 MUSCLE DISORDER 1 0.0001
678 ASPHYXIA 1 0.0001
679 HICCUPS 1 0.0001
680 HYPERAESTHESIA 1 0.0001
681 ESCHERICHIA INFECTION 1 0.0001
682 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
683 ACUTE CORONARY SYNDROME 1 0.0001
684 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
685 EMBOLISM 1 0.0001
686 HEMIPLEGIA 1 0.0001
687 CELLULITIS 6 0.0001
688 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
689 DRUG INEFFECTIVE 156 0.0001
690 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
691 MUSCULOSKELETAL DISCOMFORT 2 0.0001
692 MYOPATHY 1 0.0001
693 PULMONARY EMBOLISM 11 0.0001
694 DIPLOPIA 3 0.0001
695 THERAPEUTIC RESPONSE DECREASED 7 0.0001
696 SUICIDE ATTEMPT 7 0.0001
697 NEUROTOXICITY 2 0.0001
698 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
699 HEART RATE DECREASED 4 0.0001
700 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
701 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
702 LEUKOCYTOSIS 2 0.0001
703 TREATMENT NONCOMPLIANCE 6 0.0001
704 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
705 MEDICATION ERROR 6 0.0001
706 NECK PAIN 6 0.0001
707 THINKING ABNORMAL 2 0.0001
708 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
709 FLANK PAIN 1 0.0001
710 HEPATIC CIRRHOSIS 2 0.0001
711 DYSARTHRIA 4 0.0001
712 ARTERIOSCLEROSIS 1 0.0001
713 COLITIS 4 0.0001
714 CONDITION AGGRAVATED 32 0.0001
715 HAEMATOTOXICITY 1 0.0001
716 PROTEINURIA 2 0.0001
717 AFFECT LABILITY 1 0.0001
718 LIVER FUNCTION TEST ABNORMAL 3 0.0001
719 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
720 HEPATOMEGALY 1 0.0001
721 BODY TEMPERATURE DECREASED 1 0.0001
722 PSYCHOTIC DISORDER 3 0.0001
723 DISABILITY 2 0.0001
724 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
725 RENAL INJURY 3 0.0001
726 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
727 BLADDER DISORDER 1 0.0001
728 BLOOD POTASSIUM DECREASED 3 0.0001
729 BRAIN INJURY 1 0.0001
730 HEPATIC FAILURE 3 0.0001
731 APHASIA 3 0.0001
732 DISCOMFORT 6 0.0001
733 BLINDNESS 4 0.0001
734 DRUG ADMINISTRATION ERROR 3 0.0001
735 EUPHORIC MOOD 1 0.0001
736 INITIAL INSOMNIA 1 0.0001
737 EAR DISCOMFORT 1 0.0001
738 EYE DISCHARGE 1 0.0001
739 DRUG-INDUCED LIVER INJURY 3 0.0001
740 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
741 HYPOTHYROIDISM 3 0.0001
742 BREAST PAIN 1 0.0001
743 MOVEMENT DISORDER 3 0.0001
744 POOR QUALITY SLEEP 2 0.0001
745 DENTAL CARIES 1 0.0001
746 BLOOD PRESSURE DECREASED 6 0.0001
747 TRANSAMINASES INCREASED 2 0.0001
748 URINARY RETENTION 3 0.0001
749 INTESTINAL PERFORATION 1 0.0001
750 PRODUCT QUALITY ISSUE 12 0.0001
751 MYALGIA 15 0.0001
752 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
753 MYOCARDIAL ISCHAEMIA 1 0.0001
754 TINNITUS 4 0.0001
755 NEOPLASM 1 0.0001
756 LETHARGY 5 0.0001
757 COVID-19 PNEUMONIA 1 0.0001
758 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
759 WHEEZING 5 0.0001
760 ATAXIA 1 0.0001
761 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
762 CEREBRAL HAEMORRHAGE 3 0.0001
763 MENTAL IMPAIRMENT 2 0.0001
764 C-REACTIVE PROTEIN INCREASED 3 0.0001
765 ADRENAL INSUFFICIENCY 1 0.0001
766 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
767 INJECTION SITE EXTRAVASATION 1 0.0001
768 HYPERCALCAEMIA 1 0.0001
769 GENERALISED OEDEMA 1 0.0001
770 MUSCULAR WEAKNESS 9 0.0001
771 GASTRIC CANCER 2 0.0001
772 HAEMATEMESIS 2 0.0001
773 INTRAOCULAR PRESSURE INCREASED 1 0.0001
774 HYPOPHAGIA 2 0.0001
775 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
776 HEPATITIS 2 0.0001
777 HYPERHIDROSIS 10 0.0001
778 ANHEDONIA 2 0.0001
779 DISORIENTATION 3 0.0001
780 FEBRILE NEUTROPENIA 5 0.0001
781 FEAR 2 0.0001
782 PALLOR 2 0.0001
783 BLOOD PRESSURE INCREASED 11 0.0001
784 HAEMOPTYSIS 2 0.0001
785 PANCYTOPENIA 4 0.0001
786 HYPONATRAEMIA 4 0.0001
787 BLINDNESS UNILATERAL 1 0.0001
788 RENAL FAILURE ACUTE 3 0.0001
789 DIALYSIS 1 0.0001
790 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
791 IMPAIRED QUALITY OF LIFE 1 0.0001
792 SOMNOLENCE 14 0.0001
793 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
794 CONFUSIONAL STATE 11 0.0001
795 URINARY INCONTINENCE 2 0.0001
796 COLON CANCER 1 0.0001
797 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
798 RESPIRATORY DISORDER 2 0.0001
799 TREMOR 11 0.0001
800 DRUG DISPENSING ERROR 1 0.0001
801 EPILEPSY 2 0.0001
802 ANKLE FRACTURE 1 0.0001
803 NERVOUS SYSTEM DISORDER 2 0.0001
804 HEAD INJURY 2 0.0001
805 RASH ERYTHEMATOUS 3 0.0001
806 CARDIAC FAILURE 5 0.0001
807 BACK DISORDER 1 0.0001
808 MANIA 1 0.0001
809 OFF LABEL USE 53 0.0001
810 DRUG LEVEL INCREASED 1 0.0001
811 HEMIPARESIS 1 0.0001
812 HEPATIC ENZYME INCREASED 4 0.0001
813 THERAPY CESSATION 3 0.0001
814 EMOTIONAL DISTRESS 7 0.0001
815 ABDOMINAL DISTENSION 6 0.0001
816 MUSCULOSKELETAL PAIN 3 0.0001
817 SPEECH DISORDER 3 0.0001
818 DRUG WITHDRAWAL SYNDROME 5 0.0001
819 PANCREATITIS 3 0.0001
820 COLD SWEAT 1 0.0001
821 LYMPHADENOPATHY 2 0.0001
822 HEAD DISCOMFORT 1 0.0001
823 DRUG ERUPTION 1 0.0001
824 GALLBLADDER DISORDER 1 0.0001
825 PNEUMONIA 18 0.0001
826 NO ADVERSE EVENT 10 0.0001
827 DRUG EFFECT INCOMPLETE 2 0.0001
828 DYSURIA 2 0.0001
829 HEPATIC STEATOSIS 1 0.0001
830 THROMBOCYTOPENIA 6 0.0001
831 ERYTHEMA 11 0.0001
832 INTESTINAL OBSTRUCTION 2 0.0001
833 ANXIETY 15 0.0001
834 DRUG INTOLERANCE 5 0.0001
835 CYTOKINE RELEASE SYNDROME 1 0.0000
836 THROMBOSIS 4 0.0000
837 FLUSHING 5 0.0000
838 PYREXIA 17 0.0000
839 MUSCLE SPASMS 9 0.0000
840 HAEMOGLOBIN DECREASED 5 0.0000
841 OSTEOPOROSIS 2 0.0000
842 HYPERSENSITIVITY 9 0.0000
843 HALLUCINATION, VISUAL 1 0.0000
844 DEEP VEIN THROMBOSIS 3 0.0000
845 DEVICE LEAKAGE 2 0.0000
846 FAECES DISCOLOURED 1 0.0000
847 MENTAL DISORDER 2 0.0000
848 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
849 INTENTIONAL PRODUCT MISUSE 4 0.0000
850 THROAT IRRITATION 2 0.0000
851 ADVERSE DRUG REACTION 4 0.0000
852 HEART RATE IRREGULAR 1 0.0000
853 SUICIDAL IDEATION 4 0.0000
854 COGNITIVE DISORDER 2 0.0000
855 BURNING SENSATION 3 0.0000
856 INJURY 3 0.0000
857 DISEASE RECURRENCE 2 0.0000
858 ANAEMIA 8 0.0000
859 BLOOD PRESSURE FLUCTUATION 1 0.0000
860 LUNG DISORDER 2 0.0000
861 LIVER INJURY 1 0.0000
862 ABASIA 1 0.0000
863 DYSGEUSIA 3 0.0000
864 DRY EYE 2 0.0000
865 LEUKOPENIA 2 0.0000
866 ASTHENIA 15 0.0000
867 HALLUCINATION 3 0.0000
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
869 INFLAMMATION 2 0.0000
870 HAEMATOMA 1 0.0000
871 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
872 ECZEMA 2 0.0000
873 JOINT STIFFNESS 1 0.0000
874 DEPRESSED MOOD 2 0.0000
875 PAIN 23 0.0000
876 PRODUCT USE ISSUE 7 0.0000
877 DYSPNOEA 21 0.0000
878 OEDEMA 2 0.0000
879 NEUTROPENIA 5 0.0000
880 ABNORMAL DREAMS 1 0.0000
881 DRUG ABUSE 3 0.0000
882 COMPLETED SUICIDE 3 0.0000
883 URTICARIA 6 0.0000
884 BLISTER 2 0.0000
885 EYE PAIN 2 0.0000
886 INFECTION 5 0.0000
887 BACK PAIN 8 0.0000
888 DYSSTASIA 1 0.0000
889 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
890 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
891 CHILLS 4 0.0000
892 ASCITES 1 0.0000
893 GASTROINTESTINAL DISORDER 3 0.0000
894 LACRIMATION INCREASED 1 0.0000
895 CHEST PAIN 6 0.0000
896 FEMUR FRACTURE 1 0.0000
897 COUGH 9 0.0000
898 PARAESTHESIA 5 0.0000
899 MIGRAINE 3 0.0000
900 PRURITUS 12 0.0000
901 CONTUSION 3 0.0000
902 HIP FRACTURE 1 0.0000
903 RHINORRHOEA 2 0.0000
904 AMNESIA 2 0.0000
905 SWELLING FACE 2 0.0000
906 EYE DISORDER 1 0.0000
907 DECREASED APPETITE 7 0.0000
908 FALL 10 0.0000
909 LIP SWELLING 1 0.0000
910 GAIT INABILITY 1 0.0000
911 EYE PRURITUS 1 0.0000
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
913 URINARY TRACT INFECTION 5 0.0000
914 HAEMORRHAGE 3 0.0000
915 DEATH 24 0.0000
916 MOBILITY DECREASED 2 0.0000
917 VOMITING 13 0.0000
918 CONSTIPATION 6 0.0000
919 EYE SWELLING 1 0.0000
920 HEPATIC FUNCTION ABNORMAL 1 0.0000
921 EPISTAXIS 2 0.0000
922 DYSPNOEA EXERTIONAL 1 0.0000
923 UNEVALUABLE EVENT 2 0.0000
924 DEPRESSION 6 0.0000
925 PALPITATIONS 3 0.0000
926 DISEASE PROGRESSION 3 0.0000
927 ABNORMAL BEHAVIOUR 1 0.0000
928 CARDIAC FAILURE CONGESTIVE 2 0.0000
929 EXTRA DOSE ADMINISTERED 1 0.0000
930 OEDEMA PERIPHERAL 3 0.0000
931 LUNG NEOPLASM MALIGNANT 1 0.0000
932 VISUAL IMPAIRMENT 3 0.0000
933 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
934 DEVICE DISLOCATION 1 0.0000
935 LIVER DISORDER 1 0.0000
936 DEHYDRATION 3 0.0000
937 MEMORY IMPAIRMENT 3 0.0000
938 NEPHROLITHIASIS 1 0.0000
939 OROPHARYNGEAL PAIN 2 0.0000
940 CARDIAC DISORDER 2 0.0000
941 NEUROPATHY PERIPHERAL 2 0.0000
942 HEADACHE 13 0.0000
943 HYPOGLYCAEMIA 1 0.0000
944 PAIN IN EXTREMITY 6 0.0000
945 DYSPEPSIA 2 0.0000
946 DIZZINESS 10 0.0000
947 CHEST DISCOMFORT 2 0.0000
948 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
949 HOSPITALISATION 3 0.0000
950 NAUSEA 15 0.0000
951 PLATELET COUNT DECREASED 2 0.0000
952 DISTURBANCE IN ATTENTION 1 0.0000
953 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
954 WEIGHT DECREASED 5 0.0000
955 INCORRECT DOSE ADMINISTERED 4 0.0000
956 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
957 ABDOMINAL PAIN 4 0.0000
958 COVID-19 3 0.0000
959 DYSPHONIA 1 0.0000
960 ARTHRALGIA 7 0.0000
961 ILL-DEFINED DISORDER 1 0.0000
962 FEELING HOT 1 0.0000
963 RASH 7 0.0000
964 INSOMNIA 4 0.0000
965 VISION BLURRED 2 0.0000
966 DEVICE MALFUNCTION 1 0.0000
967 FATIGUE 11 0.0000
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
969 MALAISE 6 0.0000
970 BRONCHITIS 1 0.0000
971 HYPOAESTHESIA 2 0.0000
972 HOT FLUSH 1 0.0000
973 DIABETES MELLITUS 1 0.0000
974 DRUG DEPENDENCE 2 0.0000
975 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
976 MYOCARDIAL INFARCTION 2 0.0000
977 MUSCULOSKELETAL STIFFNESS 1 0.0000
978 DEVICE ISSUE 1 0.0000
979 ADVERSE EVENT 1 0.0000
980 BLOOD GLUCOSE INCREASED 2 0.0000
981 DYSPHAGIA 1 0.0000
982 GAIT DISTURBANCE 2 0.0000
983 ALOPECIA 2 0.0000
984 ABDOMINAL PAIN UPPER 2 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
986 INFLUENZA 1 0.0000
987 ASTHMA 1 0.0000
988 ABDOMINAL DISCOMFORT 1 0.0000
989 CEREBROVASCULAR ACCIDENT 1 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
991 DIARRHOEA 3 0.0000
992 INJECTION SITE PAIN 1 0.0000